Alitretinoin - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Alitretinoin

Brand Name:

Panretin

Strength:

0.10%

HCPCS:

NA

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

Immunomodulator

Minor Drug Class:

Retinoic Acid Derivative

Oral (Y/N):

No

FDA Approval Year:

1999

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use